206 related articles for article (PubMed ID: 1544199)
1. Use of propofol for the prevention of chemotherapy-induced nausea and emesis in oncology patients.
Scher CS; Amar D; McDowall RH; Barst SM
Can J Anaesth; 1992 Feb; 39(2):170-2. PubMed ID: 1544199
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant propofol enables better control of nausea and emesis secondary to chemotherapy for breast cancer.
Borgeat A; Wilder-Smith O; Forni M; Suter PM
Can J Anaesth; 1994 Nov; 41(11):1117-9. PubMed ID: 7828261
[TBL] [Abstract][Full Text] [Related]
3. A retrospective review of antiemetic use for chemotherapy-induced nausea and vomiting in pediatric oncology patients at a tertiary care center.
Aseeri M; Mukhtar A; Al Khansa S; Elimam N; Jastaniah W
J Oncol Pharm Pract; 2013 Jun; 19(2):138-44. PubMed ID: 23034405
[TBL] [Abstract][Full Text] [Related]
4. Dose-ranging evaluation of the antiemetic efficacy of intravenous dolasetron in patients receiving chemotherapy with doxorubicin or cyclophosphamide.
Hesketh PJ; Gandara DR; Hesketh AM; Facada A; Perez EA; Webber LM; Martin LA; Cramer MB; Hahne WF
Support Care Cancer; 1996 Mar; 4(2):141-6. PubMed ID: 8673351
[TBL] [Abstract][Full Text] [Related]
5. Infusion of palonosetron plus dexamethasone for the prevention of chemotherapy-induced nausea and vomiting.
Hajdenberg J; Grote T; Yee L; Arevalo-Araujo R; Latimer LA
J Support Oncol; 2006 Oct; 4(9):467-71. PubMed ID: 17080735
[TBL] [Abstract][Full Text] [Related]
6. Comparable safety and antiemetic efficacy of a brief (30-second bolus) intravenous granisetron infusion and a standard (15-minute) intravenous ondansetron infusion in breast cancer patients receiving moderately emetogenic chemotherapy.
Perez EA; Lembersky B; Kaywin P; Kalman L; Yocom K; Friedman C
Cancer J Sci Am; 1998; 4(1):52-8. PubMed ID: 9467047
[TBL] [Abstract][Full Text] [Related]
7. Propofol in chemotherapy-associated nausea and vomiting.
Phelps KC; Restino MS
Ann Pharmacother; 1996 Mar; 30(3):290-2. PubMed ID: 8833566
[TBL] [Abstract][Full Text] [Related]
8. Infusions of subhypnotic doses of propofol for the prevention of postoperative nausea and vomiting.
Montgomery JE; Sutherland CJ; Kestin IG; Sneyd JR
Anaesthesia; 1996 Jun; 51(6):554-7. PubMed ID: 8694208
[TBL] [Abstract][Full Text] [Related]
9. Comparison of single-dose oral granisetron versus intravenous ondansetron in the prevention of nausea and vomiting induced by moderately emetogenic chemotherapy: a multicenter, double-blind, randomized parallel study.
Perez EA; Hesketh P; Sandbach J; Reeves J; Chawla S; Markman M; Hainsworth J; Bushnell W; Friedman C
J Clin Oncol; 1998 Feb; 16(2):754-60. PubMed ID: 9469367
[TBL] [Abstract][Full Text] [Related]
10. Contribution to the treatment of nausea and emesis induced by chemotherapy in children and adolescents with osteosarcoma.
Luisi FA; Petrilli AS; Tanaka C; Caran EM
Sao Paulo Med J; 2006 Mar; 124(2):61-5. PubMed ID: 16878187
[TBL] [Abstract][Full Text] [Related]
11. [Chemotherapy induced-vomiting--a practical guide for prevention and therapy].
Jordan K; Voigt W; Schmoll HJ
Dtsch Med Wochenschr; 2006 Aug; 131(34-35):1869-72. PubMed ID: 16915549
[TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of a continuous infusion, patient controlled anti-emetic pump to facilitate outpatient administration of high-dose chemotherapy.
Dix S; Cord M; Howard S; Coon J; Belt R; Geller R
Bone Marrow Transplant; 1999 Sep; 24(5):561-6. PubMed ID: 10482943
[TBL] [Abstract][Full Text] [Related]
13. The safety of antiemetic medications for the prevention of chemotherapy-induced nausea and vomiting.
Navari RM
Expert Opin Drug Saf; 2016; 15(3):343-56. PubMed ID: 26699406
[TBL] [Abstract][Full Text] [Related]
14. Phase II trial of ramosetron plus dexamethasone in the prevention of cisplatin-induced nausea and vomiting.
Voravud N; Sriuranpong V
J Med Assoc Thai; 2005 Dec; 88(12):1790-6. PubMed ID: 16518975
[TBL] [Abstract][Full Text] [Related]
15. Prevention of delayed emesis by a single intravenous bolus dose of 5-HT3-receptor-antagonist in moderately emetogenic chemotherapy.
Massidda B; Ionta MT
J Chemother; 1996 Jun; 8(3):237-42. PubMed ID: 8808724
[TBL] [Abstract][Full Text] [Related]
16. Acupuncture against chemotherapy-induced nausea and vomiting in pediatric oncology. Interim results of a multicenter crossover study.
Reindl TK; Geilen W; Hartmann R; Wiebelitz KR; Kan G; Wilhelm I; Lugauer S; Behrens C; Weiberlenn T; Hasan C; Gottschling S; Wild-Bergner T; Henze G; Driever PH
Support Care Cancer; 2006 Feb; 14(2):172-6. PubMed ID: 16021478
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of three oral dosages of ondansetron in the prevention of nausea and emesis associated with cyclophosphamide-doxorubicin chemotherapy.
Fraschini G; Ciociola A; Esparza L; Templeton D; Holmes FA; Walters RS; Hortobagyi GN
J Clin Oncol; 1991 Jul; 9(7):1268-74. PubMed ID: 1828499
[TBL] [Abstract][Full Text] [Related]
18. Fosaprepitant for the prevention of chemotherapy-induced nausea and vomiting.
Ruhlmann CH; Herrstedt J
Expert Rev Anticancer Ther; 2012 Feb; 12(2):139-50. PubMed ID: 22316362
[TBL] [Abstract][Full Text] [Related]
19. Chemotherapy-induced nausea and vomiting. Easing patients' fear and discomfort with effective antiemetic regimens.
Bilgrami S; Fallon BG
Postgrad Med; 1993 Oct; 94(5):55-8, 62-4. PubMed ID: 8415336
[TBL] [Abstract][Full Text] [Related]
20. Chemotherapy-induced nausea and vomiting.
Bender CM; McDaniel RW; Murphy-Ende K; Pickett M; Rittenberg CN; Rogers MP; Schneider SM; Schwartz RN
Clin J Oncol Nurs; 2002; 6(2):94-102. PubMed ID: 11889684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
